2023

1. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

   Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393

2. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

   Neoplasia (United States), Vol. 42